Insulin Resistance, Hyperglycemia, and Atherosclerosis

Slides:



Advertisements
Similar presentations
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
Advertisements

The Metabolic Basis of Pulmonary Arterial Hypertension Gopinath Sutendra, Evangelos D. Michelakis Cell Metabolism Volume 19, Issue 4, Pages (April.
Peter Libby, MD  The American Journal of Medicine 
Joseph P. Kolb, Jennifer Martinez  Immunity 
Lymphatics as a New Active Player in Reverse Cholesterol Transport
Volume 14, Issue 2, Pages (August 2011)
Ghrelin—a new player in glucose homeostasis?
Obesity and Cancer: The Oil that Feeds the Flame
Volume 15, Issue 5, Pages (May 2012)
Interleukins and Atherosclerosis: A Dysfunctional Family Grows
Volume 17, Issue 6, Pages (June 2013)
Obesity, inflammation, and liver cancer
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Volume 17, Issue 5, Pages (May 2013)
Matthew Spite, Joan Clària, Charles N. Serhan  Cell Metabolism 
Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis
Assisted Living in the Atheroma: Elderly Macrophages Promote Plaques
Macrophage Metabolism Shapes Angiogenesis in Tumors
Gal3 Links Inflammation and Insulin Resistance
The marriage of glucose and blood vessels: It isn’t all that sweet
Volume 7, Issue 5, Pages (May 2008)
Unlocking the biology of RAGE in diabetic microvascular complications
VEGF-B Improves Metabolic Health through Vascular Pruning of Fat
Nat. Rev. Cardiol. doi: /nrcardio
Volume 15, Issue 3, Pages (March 2012)
AMPK Keeps Tumor Cells from Starving to Death
Arterial wall: structure and function
The CAMplexities of Central Ghrelin
Treating Obesity? It's in the Bag!
Life Is Short, if Sweet Cell Metabolism
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Autophagy: A Sweet Process in Diabetes
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Autophagy: A Potential Link between Obesity and Insulin Resistance
Obesity, Inflammation, and Insulin Resistance
IKKɛ: A Bridge between Obesity and Inflammation
VEGF-B Improves Metabolic Health through Vascular Pruning of Fat
Volume 7, Issue 5, Pages (May 2008)
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Lucas Onder, Burkhard Ludewig  Immunity 
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Oxidative stress, AGE, and atherosclerosis
A Ceramide-Centric View of Insulin Resistance
Banking on ATM as a new target in metabolic syndrome
Dietary Fat Inflames CD4+ T Cell Memory in Obesity
Volume 15, Issue 3, Pages (March 2012)
Insulin Resistance in the Defense against Obesity
Monocyte-Macrophages and T Cells in Atherosclerosis
Volume 14, Issue 2, Pages (August 2011)
Intratumoral hypoxia, radiation resistance, and HIF-1
Benjamin Lockshin, MD, Yevgeniy Balagula, MD, Joseph F
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
An IRKO in the Podo: Impaired Insulin Signaling in Podocytes and the Pathogenesis of Diabetic Nephropathy  Susan B. Gurley, Thomas M. Coffman  Cell Metabolism 
The Biological Role of Inflammation in Atherosclerosis
Ann Marie Schmidt, Kathryn J. Moore  Cell Metabolism 
Macrophages in the Pathogenesis of Atherosclerosis
Treating Diabetes by Blocking a Vascular Growth Factor
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
TOR and Aging: Less Is More
Benjamin P. Garfinkel, Gökhan S. Hotamisligil  Molecular Cell 
Sander Lefere, Frank Tacke  JHEP Reports 
Macrophages, Immunity, and Metabolic Disease
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
Of Mice and Men: Not ExAKTly the Same?
IL-1β Activation as a Response to Metabolic Disturbances
Oxygenated Lipids: A Mode to WiPE Out Inflammation?
NF-κB, Inflammation, and Metabolic Disease
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Insulin Resistance, Hyperglycemia, and Atherosclerosis Karin E. Bornfeldt, Ira Tabas  Cell Metabolism  Volume 14, Issue 5, Pages 575-585 (November 2011) DOI: 10.1016/j.cmet.2011.07.015 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Possible Mechanisms through which Insulin Resistance in ECs, VSMCs, and Macrophages Promotes Atherogenesis In early/mid-stage atherosclerotic lesions, insulin resistance is associated with a decrease in eNOS activation and NO production and increase in VCAM-1 expression by arterial ECs. Both of these perturbations may be due to downregulation of the insulin receptor-Akt1 pathway in ECs. The net effect is endothelial dysfunction and activation, leading to defective vasodilation and increased entry of inflammatory cells into the plaque. Inset, summary scheme of canonical insulin receptor signaling pathway; see text for details. Lps, lipoproteins. Cell Metabolism 2011 14, 575-585DOI: (10.1016/j.cmet.2011.07.015) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Possible Mechanisms through which Insulin Resistance in ECs, VSMCs, and Macrophages Promotes Advanced Plaque Progression In advanced plaques, insulin resistance may promote apoptosis of all three major cell types. Death of VSMCs can lead to fibrous cap thinning, while death of macrophages, coupled with defective phagocytic clearance of the cells (efferocytosis), promotes plaque necrosis. Both fibrous cap thinning and plaque necrosis can precipitate plaque rupture and acute thrombotic vascular occlusion. Not shown in this scheme is the possibility that elevated saturated fatty acids associated with obesity and insulin resistance causes defective efferocytosis of apoptotic macrophages. Cell Metabolism 2011 14, 575-585DOI: (10.1016/j.cmet.2011.07.015) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 Possible Mechanisms through which Hyperglycemia in ECs, VSMCs, and Macrophages Promotes Atherogenesis Hyperglycemia may accelerate formation of early/mid-stage lesions of atherosclerosis by promoting adhesion molecule expression in ECs through epigenetic changes, increased flux through the AR pathway, and maybe through activation of PKC, RAGE, and increased reactive oxygen species (ROS) levels. Increased adhesion molecule expression leads to increased monocyte/macrophage accumulation and atherogenesis. In VSMCs, a principal effect of increased glucose uptake appears to be increased secretion of the chemokine MCP-1, which could act in concert with the EC changes to bring more monocytes into the growing lesion. Diabetes/hyperglycemia also promotes an inflammatory phenotype in macrophages, which most likely further contributes to early atherogenesis. The effects of hyperglycemia on both ECs and macrophages are most pronounced in the presence of an inflammatory environment. Lps, lipoproteins. Cell Metabolism 2011 14, 575-585DOI: (10.1016/j.cmet.2011.07.015) Copyright © 2011 Elsevier Inc. Terms and Conditions